|
General Information
|
|
|
Product
|
FGD3 Peptide
|
|
Description
|
Antigenic Blocking Peptide Faciogenital dysplasia 3 Antibody
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Immunogen
|
Synthetic peptide taken within amino acid region 250-320 on human FYVE, RhoGEF and PH domain-containing protein 3.
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q5JSP0
|
|
Overview
|
Promotes the formation of filopodia. May activate CDC42, a member of the Ras-like family of Rho- and Rac proteins, by exchanging bound GDP for free GTP. Plays a role in regulating the actin cytoskeleton and cell shape.
|
|
Molecular Function
|
guanyl-nucleotide exchange factor activity
metal ion binding
Rho guanyl-nucleotide exchange factor activity
small GTPase binding
|
|
Subcellular Location
|
Cytoplasm
|
|
Structure
|
Repeat, Zinc-finger
|
|
Alternative Nomenclature
|
Faciogenital dysplasia 3 antibody
FGD1 family, member 3 antibody
FGD3 antibody
FYVE antibody
FYVE, RhoGEF and PH domain containing 3 antibody
ZFYVE5 antibody
Zinc finger FYVE domain containing protein 5 antibody
|
| |
|
FGD3 Antibody
FGD3 Antibody BIOTIN
FGD3 Antibody FITC
FGD3 Positive Control
